https://www.selleckchem.com/pr....oducts/grazoprevir.h
03 mmol/L vs. 4.19 mmol/L respectively, P=0.001). There was no difference in short term recurrence of atrial fibrillation in the HCT group compared to the propensity score matched control group (41.0% [N.=64] vs. 45.5% [N.=71], P=0.424). In the comparison between the first and the fourth quartile of baseline serum potassium values, no difference in AF recurrence (38.2% [N.=63] vs. 37.0% [N.=61], P=0.82 during a 3-month follow-up after ablation was observed between both groups. Patients on HCT therapy showed no difference in short
Like
Comment
Share
